Table 5 Pathway analysis of liver subcutaneous tissue
Term name | Description | FDR value |
|---|---|---|
hsa01100 | Metabolic pathways | 2.96E−16 |
hsa00071 | Fatty acid degradation | 1.82E−12 |
hsa00010 | Glycolysis/gluconeogenesis | 2.62E−10 |
hsa04022 | cGMP-PKG signaling pathway | 1.32E−9 |
hsa00350 | Tyrosine metabolism | 7.99E−9 |
hsa04970 | Salivary secretion | 7.99E−9 |
hsa04270 | Vascular smooth muscle contraction | 1.19E−7 |
hsa04923 | Regulation of lipolysis in adipocytes | 2.74E−7 |
hsa04261 | Adrenergic signaling in cardiomyocytes | 3.41E−7 |
hsa00830 | Retinol metabolism | 1.04E−6 |
hsa00380 | Tryptophan metabolism | 2.77E−6 |
hsa05204 | Chemical carcinogenesis | 3.69E−6 |
hsa00280 | Valine, leucine and isoleucine degradation | 5.55E−6 |
hsa00982 | Drug metabolism—cytochrome P450 | 7.01E−6 |
hsa04020 | Calcium signaling pathway | 7.01E−6 |
hsa00410 | Beta-Alanine metabolism | 3.07E−5 |